Abivax SA (ABVX)
NASDAQ: ABVX · IEX Real-Time Price · USD
12.40
-0.45 (-3.50%)
At close: Jul 19, 2024, 4:30 PM
12.34
-0.06 (-0.48%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Abivax Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Abivax stock have an average target of 34.2, with a low estimate of 16 and a high estimate of 50. The average target predicts an increase of 175.81% from the current stock price of 12.40.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 20, 2024.
Analyst Ratings
The average analyst rating for Abivax stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 2 | 2 | 2 |
| Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Initiates $43 | Strong Buy | Initiates | $43 | +246.77% | May 20, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +303.23% | Apr 29, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $42 | Buy | Initiates | $42 | +238.71% | Apr 29, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $15 → $16 | Hold | Maintains | $15 → $16 | +29.03% | Apr 11, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $20 | Buy | Initiates | $20 | +61.29% | Nov 14, 2023 |
Financial Forecast
Revenue This Year
1.29M
from 4.62M
Decreased by -72.19%
Revenue Next Year
19.13M
from 1.29M
Increased by 1,388.33%
EPS This Year
-2.40
from -3.43
EPS Next Year
-2.52
from -2.40
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 5.3M | 78.8M | 21.9M | 403.1M | 939.7M |
| Avg | 1.3M | 19.1M | 9.1M | 158.7M | 440.5M |
| Low | n/a | n/a | n/a | 60.7M | 174.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 13.6% | 6,028.4% | 14.7% | 4,307.3% | 492.2% |
| Avg | -72.2% | 1,388.3% | -52.2% | 1,635.0% | 177.6% |
| Low | - | - | - | 563.7% | 9.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.99 | -2.52 | -2.43 | 0.21 | 3.09 |
| Avg | -2.40 | -2.52 | -3.15 | 0.21 | 3.00 |
| Low | -2.68 | -2.50 | -3.78 | 0.20 | 2.88 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 1,393.0% |
| Avg | - | - | - | - | 1,350.3% |
| Low | - | - | - | - | 1,293.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.